Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Healthcare
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Ignore that clown randomtask
View:
Post by whisky11 on Aug 31, 2021 5:59pm

Ignore that clown randomtask

there is a couple of them attacking smaller companies I stood up to them. They working for someone with the money.
But that's not a problem, what I want to say is that in few months we will know how good R-107 is. 
If it meets expectation then... congratulation to all longs.
 
Comment by Chritters on Sep 01, 2021 11:01am
I ignore all you clowns, The only one with common sence on here is Raiders!!
Comment by randomtask on Sep 01, 2021 1:25pm
Don't be so sour about being out of your element;  investing, business, math and common sense simply aren't your strong suit :)
Comment by Raiders11 on Sep 01, 2021 3:24pm
This post has been removed in accordance with Community Policy
Comment by randomtask on Sep 01, 2021 4:01pm
This post has been removed in accordance with Community Policy
Comment by Raiders11 on Sep 01, 2021 4:06pm
This post has been removed in accordance with Community Policy
Comment by Raiders11 on Sep 01, 2021 4:09pm
This post has been removed in accordance with Community Policy
Comment by randomtask on Sep 01, 2021 4:09pm
This post has been removed in accordance with Community Policy
Claritas Pharmaceuticals Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities